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ABSTRACT

The metabolic control of citrate synthase by the inhibitory
effect of ATP has been repeatedly proposed.

The reaction catalysed by

citrate synthase in crude extracts of several tissues is shown to be
inhibited by ATP.
CoA.
%
tion

This inhibition is competitive with respect to acetyl-

Low levels of Mg"*"*, however, relieve the inhibition by ATP and
concentrations one hundred fold greater than acetyl-CoA concentra
inhibit the citrate synthase catalysed reaction.

The suggestion

has been made that Mg'*4’ binds to the polyphosphate group of acetyl-CoA
so that it is unable to interact with the enzyme.

Similarly, Mg++ may

bind with the polyphosphate group of ATP so that it cannot act as an
inhibitor for the enzymatic reaction.
-I

In vitro studies of complex

|

formation between Mg

*f“ | '

and ATP support this suggestion.

When Mg

and

ATP are present in equal concentration during the citrate synthase
reaction, no inhibition is observed.

Results of these experiments are

considered in terms of the citrate synthase reaction mechanism and of
metabolic control and bring into doubt the role of ATP as a metabolically
significant controller.

ii
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CHAPTER 1
INTRODUCTION
A.

STOICHIOMETRY
Citrate synthase (citrate oxalacetate-lyase(CoA-acetylating)

EC 4.1,3.7) catalyzes the condensation of OAA with acetyl-CoA to fora
citrate and CoA (equation i):

OAA~ +

acetyl-CoA

+

HgO

citrate* +

CoA

+

H+
(equation i)

This aldol condensation involves the methyl group of the acetyl moiety
in acetyl-CoA and the carbonyl of OAA,

In the early days of investi

gation, acetic acid itself was known not to take part in the enzymic
reaction; thus, the notion of an active acetate came about (1). Evidence
was found to support the supposition that the active acetate was formed
by oxidation of fatty acids from ft -keto acids such as acetoacetic acid
and from acetic acid (2,3,^,5*6,7,8,9,10).

Then it became apparent

that a coenzyme was necessary for these acetylation reactions (11,12),
This coenzyme was called coenzyme A (13),

Isolation and purifi

cation showed that it was composed of pantothenic acid, adenylic acid or
a related nucleotide (1^,15) and a sulfhydryl compound attached to the
pantothenic acid (15,16).

The sulfur compound was then shown to be

^-mercaptoethanolamine attached to pantothenic acid by a peptide bond
(17,18).

Previous experiments using yeast cells deficient in pantothenic

acid indicated that CoA could be involved in the formation of citric acid
(19),

Using a soluble enzyme preparation, Stern and Ochoa synthesized

citrate from OAA, acetate and ATP; CoA was required for activity (20),

'1
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2
Acetoacetate and other/3-keto acids (21) were acetyl donors during citrate
formation in pigeon liver preparations.

Stadtman then reported (22)

that CoA functioned as an acetyl transfer agent in a pho sphotransacetylase
system from bacteria.

Novell! and Lipmann (23) found that acetyl phos

phate was an acetyl donor for citrate synthesis.

These facts led S t e m

and Ochoa (2*0 to propose the formation of acetyl-CoA from acetyl phos
phate and CoA; subsequent interaction of acetyl-CoA with OAA formed
citrate and CoA.
Lynen and Reichert (25) isolated acetyl-CoA from yeast and showed
that this substance could replace either acetate and ATP or acetyl phos
phate as an acetyl donor in the acetylation of sulfonamide by a crude
extract of pigeon liver.

A similar function for acetyl-CoA was found

in the acetylation of p-aminobenzoic acid (26,27).

Then, Stern using

crydfalline CS demonstrated that in place of the transacetylase-acetyl
phosphate system, acetyl-CoA could fill the role of acetyl donor in the
synthesis of citrate.

Upon studying the properties of acetyl-CoA,

Stadtman (29) confirmed the conclusions of Lynen and Reichert (25) that
the acetyl group of acetyl-CoA was attached by thioester linkage to the
thioethanolamine moiety of CoA.

Stern (30)* by measuring the quantities

of substrates and products at equilibrium, found that citrate synthase
had a high affinity for acetyl-CoA and that the acetyl-mercaptide bond
of acetyl-CoA was energy rich.

They reported the apparent equilibrium

constant of the overall reaction to be 8.38 x 10^ litres/mol© at pH 7.2

and 22° C.

B.

.

MECHANISM
All this investigation led to further experiments which attempted

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

to show th© mechanism of the CS catalysed reaction.

It was known that a

carbon-carbon bond is formed between the methyl carbon of acetyl-CoA and
the carbonyl of OAA.

This may be considered a mixed aldol condensation.

It was also known that non-enzymatically, these reactions take place
when a proton c( to a carbonyl is lost.

This rate-determining step is

followed by the attack of this anion on the positively-charged carbonyl
carbon of another reacting molecule.

Bove (31). investigating this

aspect of the CS reaction, showed that OAA had to be present in order
that tritium be incorporated into the terminal methyl group of acetyl-CoA
from the medium.

When acetyl-CoA, tritiated in the acetyl group, took

part in the enzymatic reaction, loss of radioactivity in the coenzyme
occurred.

It was concluded that OAA was necessary for removal of an

©(-hydrogen from the acetyl group of acetyl-CoA and that this loss was
rate-determining.

Similar conclusions were reached by Marcus and

Vennesland (32) who used D^O,

Englard (33) used deuterated OAA to show

that the keto form of OAA is the reactive tautomer in the CS reaction.
Srere and Kosicki (3*0 devised a method of purification for CS
and reported the CS content of a variety of tissues.

Under the conditions

used, the amount and purity of the enzyme were increased over previous
methods.

Using an enzyme of high purity, they studied the effect of pH

on Vraax, Km and the rates of the forward and reverse reactions (35).

It

was found that the pH optimum was different for the forward and reverse
reactions.

Dalzlel*s kinetic expression (36) for a two-substrate reaction,

where one substrate may act as a competitive inhibitor, fit the data0
From experiments using normal and deuteroacetyl-CoA in H2O and DgO (3?)»
Kosicki and Srere concluded that the removal of a proton from the c(-methyl

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

group of acetyl-CoA was rate-limiting or very nearly so.

They also

observed a shift in the activity curve of CS in the presence of DjjO.

If

the enzyme-substrate complex reacts maximally when particular groups on
the complex are dissociated, the more tightly bonded deuterium would be
expected to shift the pH dependent activity curve in the direction observed
in these experiments.
genase (38)•

These are similar to findings with lactate dehydro

During a study of the binding of OAA to CS, Srere found

that formation of an OAA-enzyme complex is accompanied by a change in
protein conformation (39.^0)•

Preincubation of the enzyme with OAA

prevents exposure in urea of protected sulfhydryl groups and loss of
activity (hi,^2).

Srere (h3) has concluded that the sulfhydryl groups

of CS are involved in Internal hydrogen bonding for maintenance of a
particular conformation at the active site; these sulfhydryl groups do
not take part directly in the enzyme-catalysed reaction.

OAA also

protects CS from heat denaturation (hh) and from palmitoyl-CoA inhibi
tion (h5,h6).

This property may have importance for control of enzyme

activity (h7)e
Evidence indicates that OAA is bound to CS through both carboxyl
groups and through the carbonyl oxygen (ho). The spectral changes
observed when OAA binds to CS were interpreted to indicate a compacting
of the protein (39)•

In terms of mechanism, these observations support

the earlier finding that exchange between the o<I-methyl proton of acetyl-CoA
and the medium occurs only in th© presence of both enzyme and OAA (31,32).
By measuring the incorporation of tritium into the acetyl group of
acetyl-CoA, Eggerer (^8) showed that L-malate aided in the removal of a
proton from the acetyl group of acetyl-CoA.

Srere (^9)» by means of

nuclear magnetic resonance, measured the ability of several compounds

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

to induce the loss of this proton from acetyl-CoA in a system containing
CS and D20 medium.

The results were similar to those of Eggerer,

Maleate, D-malate, pyruvate, dimethylglutarate and succinate allowed no
exchange of protons,

L-Malate or OAA induced proton removal.

When OAA becomes bound to the active site of CS, there occurs in
the enzyme a conformational change (only partial when L-malate is used)
which brings a group on the enzyme into a more favorable position for
removal of the <X-methyl proton of acetyl-CoA (**9).
The nature of the thioester linkage in acetyl-CoA makes it suit
able as an acetyl donor.

Sulfur is electronegative (i.e. willing to

accept electrons) and has unfilled d orbitals just above the outer electron
shell.

These are not very different in energy from the outer p orbitals.

Since sulfur's electronic configuration is only two electrons short of
the corresponding rare gas, this element forms stable anions.
physiological pH and temperature, acetyl-CoA is stable.

At

Since sulfur

tends to hold on to its electrons, it tends not to participate in
resonance.

When an acetyl group is attached to a sulfur as in acetyl-CoA,

the electronegativity of oxygen polarizes the C=0 bond in the direction
of oxygen.

Similarly, the electrons of the C-S bond are polarized

toward sulfur (50).

This leaves the carbonyl carbon relatively positive.

This in turn causes polarization of a C-H bond.

A proton is released -

and the carbanion formed is stabilized by resonance (Diagram i).

Since

this proton loss from acetyl-CoA requires the presence of both OAA and CS,
this reaction ’takes place in an environment in which spatial arrangement
and electronic configuration of atoms are specific and transitional.

The

attack of the carbanion on the carbonyl of OAA is followed by a nucleophilic substitution at the acyl carbon of acetyl-CoA (51) with simultaneous
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cleavage of the acyl-sulfur bond.

Suelter and Arrington (52) used H2O

to show that oxygen from H2O in the medium becomes associated with the
carboxyl of citrate derived from acetyl-CoA.

Then as suggested by

Eggerer (^8), CS has the following three catalytic functions; enolase,
ligase and hydrolase (Diagram 2).

9

+

H-CH2-C-SCoA

H

+

■_

9

CH2-C-SC0A

-0
CH2-C-SCoA

Diagram 1

-

0 9=0
-

CH0-C-SC0A

0=C
*

enolase

0- (
H

-

0 9=0

0

-

~ 0-C+<-CH2-b-SCoA
6h?
- 0-6=<)
H+

0 9=0
-

ligase

"0

O-C-CH2-C....SCoA
9H2
i
+
0-C=0
'OH
H

hydrolase

Diagram 2
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7
C.

METABOLIC CONTROL
The reaction catalyzed by CS merits consideration since it occupies

a position in metabolism where carbohydrate, fat and protein metabolism
merge and diverge,

Oxalacetate, pyruvate and^-ketoglutarate may be

formed respectively from aspartate, alanine and glutamate by transamination,
Acetyl-CoA, a substrate in the CS reaction, may enter the tricarboxylic
acid cycle by way of this reaction or, by means of acetyl-CoA carboxylase,
take part in the synthesis of malonyl-CoA to eventually form long chain
fatty acidsj acetyl-CoA may be transformed to keto acids such as aeetoacetate or return to glucose during gluconeogenesis.

Therefore, it is

probable that control of the CS reaction is well integrated with other
pathways by means of one or more mechanisms.
The observed in vivo activity of an enzyme depends on how much
enzyme is present and on the state of these molecules —
act as catalysts.

their ability to

Although th© enzyme content of a tissue may have a

role in control of CS activity, it has generally been found that de novo
synthesis and degradation of enzyme molecules would take place too slowly
to be effective as a fine control (53)•

Previous observations have shown

that changes in conformation of proteins do occur on association with
protons, substrate or product molecules, coenzymes, metal ions or other
proteins resulting in simultaneous changes in activity.

Thus, metabolism

may be regulated at the enzyme level by availability of modifiers of
protein (enzyme) structure.
This availability is controlled by synthesis and degradation of
modifiers, by transport across membranes or by competition for modifiers
between proteins (enzymes) and other molecules or ions.
S t e m and Ochoa (24-) reported that ATP inhibited the synthesis of

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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citrate in a soluble enzyme system prepared from acetone-dried pigeon
liver*

Yeast CS kinetic properties were altered in the presence of

adenine nucleotides (5*0«

ATP when present in physiological concentrations

altered the activity more than other nucleotides.

A control mechanism

analogous to isocitrate dehydrogenase was proposed for CS,

NAD-specific

isocitrate dehydrogenase had been shown (55) to possess increased activity
in the presence of AMP and decreased activity in the presence of ATP.
Therefore, it was proposed that ATP regulation of CS activity was part
of a mechanism by which the energy state of the cell (proportional to the
ATP level) controlled the fate of acetyl-CoA.

The finding that citrate

stimulates acetyl-CoA carboxylase (56,57*58) implied added importance to
the speculation that regulation of CS activity directs acetyl-CoA incorp
oration into fatty acids or into the tricarboxylic acid cycle (5*0 *
ATP inhibition of CS is competitive with acetyl-CoA in pig heart
(5**»59) * yeast (5*0* beef heart, beef liver, and Escherischia coli (60,61).
ATP also inhibits this enzyme from rat liver mitochondria (62) and lemon (63).
Jangaard recently reported (6^) that ATP inhibition of partially purified
Escherischia coli CS was not competitive with respect to acetyl-CoA. Kosicki
and Lee (59) have shown that pig heart CS is inhibited by ATP, ADP, GTP,GDP, ITP, IDP, palaitoyl-CoA, NADH and NADPH,

In each case, however, the

•

inhibition is relieved by increasing concentration of acetyl-CoA. Furthermore,
the metal ions Mn++, Mg**, and Ca**, which inhibit the reaction competi
tively with respect to acetyl-CoA at low concentration, relieve the
inhibition of -the nucleotide derivatives.

It is suggested (59,65) that

this relief of inhibition is due to chelation of divalent metal ion with
the polyphosphate portion of the inhibitor molecules.

By this reasoning,

the inhibition of the CS reaction by metal ions is interpreted to mean
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that in the normal reaction acetyl-CoA becomes bound to the enzyme through
its polyphosphate group (65).

These observations of divalent metal ion

relief of inhibition bring into serious question whether ATP in vivo plays
a role in the regulation of CS because of the high physiological level of

In order to determine whether these characteristics of inhibition
of the CS catalysed reaction are significant to the control of the reaction,
we have used crude extracts of a number of tissues.

Experimental design

and treatment of data were carried out in order to answer the following:
Does ATP always inhibit CS?
to acetyl-CoA?

Is this inhibition competitive with respect

Does Mg++ relieve this inhibition?

It was found that in each of the tissues studied, ATP inhibition
of CS was competitive with respect to acetyl-CoA, and Mg
inhibition.

relieved the

These results are in agreement with previous findings that

ATP inhibits CS competitively with respect to acetyl-CoA (5^.59.60,61,65)•
Mg++ relieves the inhibition due to ATP and optimum activity is observed
when ATP and Mg

are present in concentrations having a 1/1 ratio as

previously reported (59.65).

In experiments using a wide concentration

range of ATP and a concentration of Mg++ such that the ATP/Mg++ ratio
was one, no inhibition was observed.
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CHAPTER 2

\
EXPERIMENTAL
A.

METHODS
1)

Growth of Yeast Cells
University of Windsor, Department of Biology, colony #195

Saccharotnyces carlsbergensls was used. Cells were grown in media consisting
of: 3*5 g peptone, *1-0.0 g dextrose, 2.0 g K^POi*, 5*0 g yeast extract and
1000 ml of water.

For aerobic growth, a 100 ml inoculum was added to the

media and growth allowed to proceed for 26 hours at 2*J-°C with continuous
stirring with a bar magnet.

For anaerobic growth, a loopful of cells was

used to inoculate media which had been flushed with nitrogen gas for 6
hours.

Growth was allowed to proceed for

was bubbled through the media continuously.

days at 37°G.

Nitrogen gas

Cells were spun down, washed

once in 0.1 M potassium phosphate buffer, pH 7.**, and frozen.

2)

Preparation of Crude Extracts
The initial steps

of

the method

of- Srere

the isolation of CS were used to prepare crude extracts.

and Kosicki(3*0 for
In this method,

10 g of tissue were extracted with *M) ml of 20 per cent ethanol, 0.** M in
potassium chloride.

Homogenization in a Waring blendor was carried out

for 10 minutes and the temperature was not allowed to exceed 18°C.

In

the case of the yeast cells, an amount of glass powder equal to the weight
Of the yeast cells was used during homogenization.

The homogenate was

centrifuged for 15 minutes at 23,000 x g and the supernatant fluid dialyzed
against 800 ml of cold 0.002 M potassium phosphate pH 7.3 for 2 hours. The
outside

fluid was changed and dialysis continued for another two hours.

The dialysate was centrifuged

at

23,000 x g

for 15 minutes.Thesupernatant

10
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fluid was used for enzyme assays and is stable for several days at 3°C.
Protein determinations were made using the Biuret method (66).

3)
'

Enzyme Assay Method

• ■ ■ a m b 'i M i

m asaB M aanaea* rw w T w tnT aw m h j b

CS activity was assayed using a coupled assay procedure.
this

assay, L-malate, NAD and an

L-malate

+

NAD+

CS catalyzes the condensation

OA/f +

9H2-C-SCoA

excess of MDHare usedto generate OAA:

-

of

In

oM

+

NADH

+ H+

the acetylgroup of acetl-CoA withOAA:

+ HgO r;-.-C-9

citrate- +

CoASH

+ H+

Therefore, as long as the MDH catalyzed reaction is not rate-limiting, the
rate of the CS catalyzed reaction may be followed by observing the reduction
of NAD at 3*K> raja.

The molar absorbancy of NADH is 6220,

Tris-acetate buffer, L-malate, NAD, acetyl-CoA, MDH and deionized
water were incubated at 25°C for 3 to k minutes.
catalyzed reaction comes to equilibrium.
by the

During this time the MDH

The CSreaction

was theninitiated

addition of crude extract and the rate recorded on aGilford Model

2000 Absorbance Recorder attached to a Beckman DU Monochromator,

The

temperature of the reaction chamber was kept constant at 25,0 1 0,2°C by
a circulating water bath.

The rate was linear for at least five minutes

after the start of the reaction and was measured over the time range from

2 to k minutes after initiation of the reaction.
Each extract was also assayed for NADH oxidase activity and this
was found to be negligible in all cases examined (A.O.D./minute at 3^0 nya

< 0 . 003).
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h)

Materials
The following were obtained commercially: L-malic acid, ATP

(Sigma); NAD, bovine serum albumin (Calblochem); CS, CoA, NADH and MDH
(Boehringer and Soehne, Mannheim),

KHCO^, MgCl2 ‘6H20, K^PO^, K2HP0^

(Fisher) and acetic anhydride (Eastman) were reagent grade,

Tris was

primary standard grade,
L-Malic acid, ATP and NAD were dissolved in water and the pH
adjusted to neutrality with solid KHCO3.

NADH was dissolved in 0.1 M

Tris-acetate buffer pH 8.2 . Molar Tris-acetate buffer was prepared by
adding molar acetic acid to molar Tris until the desired pH was reached.
Similarly, molar phosphate was prepared using molar solutions of KH2PO4
and K2HP0j^.
Commercial CS, MDH and crude extracts were diluted in 0,02 M
potassium phosphate buffer pH 7«3 containing 1 mg/ml of bovine serum
albumin,

■
Acetyl-CoA was prepared according to the method of Simon and

Shemin (67).

CoA is very hygroscopic making it difficult to weigh small

amounts accurately; it was important to know the concentration of acetylCoA for the competitive inhibition studies.

Therefore, the concentration

of acetyl-CoA in the prepared stock solution was determined by using a
measured amount of this substrate in the coupled assay system containing
an excess of commercial CS,

After ten minutes, when the reaction was completed,

the amount of NADH formed was measured at 3^0 rap. against a reaction
mixture containing no acetyl-CoA (blank),

Since one molecule of NADH is

formed for each molecule of acetyl-CoA reacting, and the CS reaction goes
to completion, then the concentration of NADH at the end of the reaction
equals the initial concentration of acetyl-CoA.
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5)

Calculations
Km is defined as being numerically equal to the concentration

of the substrate which permits half-maximal velocity.

Ki is the concentra

tion of the inhibitor that slows the reaction to half the rate observed
when no inhibitor is present.

In these studies, Km and Ki were calculated

using Lineweaver-Burk plots of reciprocal of initial velocity versus
reciprocal of substrate concentration (68).

Initial velocities (V0) were

calculated from the slopes of the chart paper data and were in units of
AO.D./minute at 3^0 mp.

The reciprocal of these values and the corresponding

reciprocal substrate (acetyl-CoA) concentration along with the least
squares program shown in the APPENDIX were run on an IBM 1620^ computer.
Data from both uninhibited and inhibited runs were treated in this way.
The computer chose the line of best fit for the uninhibited run and
another line for the inhibited run.

From the slopes and x-axis intercepts

of these lines, Km and Ki were calculated,.
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14B.

RESULTS
1)

Inhibition of CS by ATP
ATP in a concentration 20 to 200 times that of acetyl-CoA

inhibits CS in a crude extract of beef heart.

The inhibition is com

petitive with respect to acetyl-CoA as shown by a Lineweaver-Burk plot
(68, Fig. 1).

ATP has the same inhibitpry effect on CS in crude extracts

of beef liver, rat heart, liver, kidney and brain, and aerobically and
anaerobically grown yeast (Table 1, columns d and e).

Increasing concen

trations of ATP led to a decline in CS activity until a minimum level was
reached at about 80 per cent of control (Fig. 2).
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Fig. i.

Competitive inhibition of ATP on CS activity

in a crude extract of beef heart.
The coupled assay procedure was used.

Each cuvette (1.0 cm light

path) contained 0.20 M Tris-acetate buffer pH 8 .36, 10 raM malate,
0.384 mM NAD, 7»2 units of MDH, beef heart crude extract containing
0.007 units of CS, acetyl-CoA and ATP as indicated and water to
lo0 ml final volume.
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Fig. 2.

Effect of ATP concentration on the rate of

the CS catalysed reaction in a crude extract of beef heart.
The coupled assay procedure was used.

Each cuvette (1.0 cm light

path) contained 0.20 M Tris-acetate buffer pH 8*30, 10 mM malate,
0.38** mM NAD, 108.0

acetyl-CoA, 8.0 units of MDH, 0.00** units

of CS in a beef heart crude extract, ATP as indicated and water
to 1.0 ml final volume.

Potassium chloride was added in

appropriate amounts from a stock solution to maintain a constant
ionic strength from one reaction to another.

The ionic strength

due to ATP and KC1 was 0.2*10 .
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2) Effect of Mg~H ~ on ATP inhibition of citrate synthase
In the absence of Mg

, concentrations of ATP approximately 75

times (5 raM ATP) and 150 times (10 mM ATP) that of acetyl-CoA are
inhibitory to CS in a beef heart crude extract (compare the y-axis
intercepts of the curves in Fig. 3» See also Table I, columns f and h).
-J- |

Increasing concentrations of Mg
Fig. 3)•
of Mg

++

are also inhibitory to CS (upper curve

In the presence of a fixed amount of ATP, increasing concentrations
lead to an increase in activity of CS (Table I, compare column f

with g and h with i) followed by a gradual decline in activity (Fig. 3)»
maximum activity is observed when ATP and %

are present in approximately

equal concentrations (two lower curves of Fig. 3)« When a wide range
of ATP concentrations is used in the presence of equal concentrations
of 1%

++

, no inhibition is observed (Fig. b). A comparison of Figs. 2

and b indicates the effect of Mg++ on the ATP inhibition of CS.
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Fig. 3»

Effect of Mg++ on ATP inhibition of CS in a

crude extract of beef heart.
The coupled assay procedure was used.

Each cuvette (1.0 cm light

path) contained 0.20 M Tris-acetate buffer pH 8.33» 10 mM malate,
0.38^ nsM NAD, 65.^

acetyl-CoA, 7*2 units of MDH, beef heart

crude extract containing 0.007 units of CS, ATP and Mg++ as
indicated and water to 1.0 ml final volume.
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Fig.

Effect of concentration of ATP on the rate

of the reaction catalyzed by CS in a crude extract of beef heart
when Mg

is present in a concentration equal to that of ATP.

The coupled assay procedure was used.

Each cuvette (i.O cm

light path) contained 0,20 M Tris-acetate buffer pH 8.30, 10 mM
malate, 0 .38^ mM NAD, 133*2 /iM acetyl-CoA, 8.0 units of MDH,
0.00^ units of CS in a beef heart crude extract, ATP and Mg++
as indicated and water to 1.0 ml final volume.

Potassium chloride

was added in appropriate amounts to maintain a constant ionic
strength from one reaction to another.

The ionic strength due

to ATP, Mg** and KC1 was O.36O .
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Table I.

Data for Enzyme Content and Summary of the

Effect of ATP and Mg** on Citrate Synthase.
The coupled assay procedure was used. .Each cuvette (1.0 cm light
path) contained 0.20 M Tris-acetate buffer pH 8.1 to 8.5» 10 mM
malate, 0.384 mM NAD, acetyl-CoA (see below), 8.0 units of MDH,

0.003 to 0.007 units of citrate synthase from the tissue indicated,
ATP and Mg** as indicated and water to 1.0 ml final volume.
For the determination of enzyme content and the effect of
Mg

on ATP inhibition, the acetyl-CoA concentration used in a

given experiment was constant; variation in the concentration of
acetyl-CoA from one experiment to another was from 3*5 to 9 times
the Km for acetyl-CoA.

To determine Km and Ki, acetyl-CoA was

used over a concentration range of 2 to 20 x Km in each experiment.
♦The extent of disruption of yeast cells during homogenization
was not determined by microscopic examination of the homogenate; the
breakage was probably partial and thus the reported values of enzyme
content of yeast are probably low.
Those values followed by (c) have been calculated by computer
as explained in A. METHODS 5)•
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Table I ■
a

b

c

d

e

f

g

h

i

Tissue Crude Total Units
Protein Specific Activity Km x 10* Ki x 103 Per cent Activity with Mg*'*' ’ ~
moles
moles
5mM ATP
IQmM ATP
Extract
Gram wet weight mg/ml
units/mg
of tissue
litre
litre
ho Mg+'r5mil Mg’*"*' Ko Mg^lQmM Mg1*'
rat liver

3<>l6

17.61s.

0.033

0.88(c)

0.52(c)

■1+7.7

91.8

1+3.6

81.1+

rat heart

28.50

7.88

0.738

1.73(c)

0.72(c)

52.8

92.1

1+1+.3

90.1

rat kidney

7.88

11.08

0.132

1.90(c)

1.13(c)

51+.5

91.3

36.7.

81.0

rat brain

1+.66

5*77

0.176

0,7>+(c)

0.1+9

51+.6

80.6

1+6.9

75.0

beef liver

1.18

13.80

0.020

2.01

3.69

73.1

86.2

66.6

80.2

beef heart

l805l

5.1+7

‘ 0.629

1.1+0

2.82

•7U *6

91 o9

62.3

83.1+

1.67

0.095

1.12

0.1+9

71.6

87.9

60.5

76.5

0.01+5

0.15(c)

0.59(c)

68.1

77.0

1+9.2

62.3

^

aerobic yeast5^

0.71+

anaerobic
yeast'

1 066

oo

7.89

IA»

PO

Vj\

Table II.

(from 69)

Total Weight and Percentage

Distribution of Metals in Rat Liver Fractions.
Values shown are the means of values obtained from examination
of livers from five groups of rat livers each of which is
composed of a sample of tissue from five animals.

Fractionation

of cellular components was carried out by the method of
Hogeboom et al.(?0).

Emission spectrography was used to

determine the metals.
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Table II

N

In
organic

4th

Cu

Mu

Zn

Ca

Fo

Ha

MC

K

• T o t a l w e ig h t in wholo liv e r, y p er gin. fresh perfused tissue
M e a n ...................
± s tan dard

19,800 12,000

e r r o r ........... ± 2 ,0 0 0

4 .7

1.3

15

± 2 0 0 ± 0 .4 7 ± 0 . 1 5 ± 1 . 3

17.4

2 2 .0

100

270

2900

± 5 .1

± 2 .2

±19

±14

±180

D is tr ib u tio n in fra c tio n s , p e r cent

C o nn ective
tissue . . . . .
N u c le i and
w hole cell
re s id u e ...........
M ito c h o n d r ia ..
M ic ro s o m c s . . .
S u p e r n a ta n t.. .

6 .3

2 .8

2 .2

2 .1

2 .4

4 .2

2 .2

2 .0

2 .2

2 .0

4 3 .9
12.4
10.7

3 7 .4
5 .1
7 .3
4 7 .5

2 0 .3
8 .2

OS.8
15.1
0 .4
7 .5

3 7 .2

4 5 .0
2 8 .2
11.9
10.7

24.4

4 7 .8
17.4
13.7
19 .2

2 5 .8
2 .7
3 .2
00.1

29.0
7 .8
2 .8
5 8 .0

2 7 .7

5 .0
0 4 .3

4 .6
12.9
4 3 .2

11.2
15.04 7 .1

—

T h e sum o f tho fra c tio n s •* tho whole liv e r re c o n s titu te d *=* 100 ± 0 . 5 p er cent.
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CHAPTER 3

DISCUSSION

A.

MECHANISM OF CITRATE SYNTHASE INHIBITION BY ATP
ATP inhibition of CS from a variety of tissues has been reported

(24,54,60,61,62,63)•

Kosicki and Lee (59) observed inhibition of a

purified pig heart CS by nucleoside di- and triphosphates, NADH, NADPH
and CoA.

This inhibition was competitive with respect to acetyl-CoA,

Examination of the structure of the inhibitory molecules as well as that
of acetyl-CoA revealed that a polyphosphate group and a purine residue
W8re common to them.

However, a lack of inhibition by 5*-AMP and 3'»5'-

cyclic AMP, appears to rule out the direct participation of the purine
residue in the observed inhibition of CS,

Accordingly, experiments were

carried out to see whether inorganic pyrophosphate were inhibitory to CS,
Inorganic pyrophosphate inhibited CS and this inhibition was competitive
with respect to acetyl-CoA; this was not an ionic strength effect (65),
We have studied this behavior using crude extracts.

Crude

extracts were used since they probably most closely approach physiological
conditions.

Concentrations of ATP approximately one hundred times that

of acetyl-CoA are competitive with respect to acetyl-CoA in their
inhibition of CS,

This was observed' Using crude dialysed extracts of

rat liver, heart, kidney and brain; beef liver and heart; and aerobically
and anaerobically grown yeast cells (Fig, i and Table I, columns f and h).
Other workers (64) have recently reported similar results: ATP inhibition
of CS purified from beef liver and heart is competitive with respect to
acetyl-CoA.

However, ATP does not inhibit competitively with respect to

acetyl-CoA in a reaction catalysed by Escherischia coli CS.

28

.
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Mg++ inhibits

29

this enzyme and relieves ATP inhibition (6^),

ATP inhibition of CS from

rat liver mitochondria was reported (62) not to be competitive with
acetyl-CoA.

This finding is not in agreement with our observation that

CS in a crude extract of rat liver is competitively inhibited by ATP,
Divalent metal ions when present in one hundred fold excess over
acetyl-CoA have been reported to be inhibitory to the reaction catalyzed
by pig heart CS (59).

This inhibition is not competitive with respect

to OAA but is reduced by an increased concentration of acetyl-CoA.
Moreover, concentrations of divalent metal ions lower than or equal to the
ATP concentration, relieve the ATP inhibition (59).

We observed similar

behavior using crude extracts of tissues (Table I),

Increasing concen

trations of Mg++ are inhibitory to CS (Fig. 3» upper curve).
presence of 5

In the

and 10 mM ATP, the CS activity increases as higher conf-

centrations of Mg

are used and maximum activity is reached when the ATP

concentration is approximately equal to the Mg++ concentration (Fig, 3»
two lower curves).

That the ATP-Mg complex is not measurably inhibitory

to the CS reaction is shown in Fig. k,

A comparison of Figs. 2 and h-

“H"
clearly points out that Mg
does prevent ATP from inhibiting the enzymatic
condensation of OAA with acetyl-CoA.

Results obtained from pH titration

experiments (71) suggest that metal ions chelate with the polyphosphate
moiety of adenosine phosphates.

The chelation of divalent metal ions

with the polyphosphate portion of acetyl-CoA would explain the inhibitory
effect of metal ions on the CS reaction if the polyphosphate of acetyl-CoA
becomes necessarily associated with the enzyme-OAA complex during the
reaction.

The inhibitory effect of inorganic pyrophosphate and its

derivatives on the CS reaction could then be interpreted to be due to
the binding of their polyphosphate group at a site on the enzyme where
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the polyphosphate of acetyl-CoA normally becomes bound.

The chelation of

metal ions with these polyphosphate derivatives would block their ability
to inhibit the CS reaction.

This would account for the observed decrease

in nucleotide inhibition of CS on addition of divalent metal ion.
In summary, evidence from previous work indicates that OAA becomes
bound to CS by both carboxyl groups and by the carbonyl oxygen (^0).
appears that the keto form of OAA (33*^8) is the substrate for CS.

It
Of

interest in this regard is the recent finding of an enzyme which catalyzes
the tautomerization of OAA (72).

The binding of OAA to enzyme is accom

panied by a change in conformation of CS (^0),

Since the binding of OAA

(or malate) is necessary for loss of a proton from the methyl group -of
acetyl-CoA, it is possible that the conformational change in CS which
occurs upon binding to OAA, causes either the carboxyl groups of OAA or
some groups on the protein to be in a favorable spatial arrangement in
order that electronic effects on an q (-proton of acetyl-CoA enhance its
removal in a rate-limiting step.

After the

-proton of acetyl-CoA has

been removed, a nucleophilic attack of the carbanion on. the carbonyl of
OAA takes place with simultaneous hydrolysis of the thioester bond.
These findings suggest that acetyl-CoA becomes bound to the enzyme at its
4 -1

polyphosphate group.

Thus, added Mg

binds with the polyphosphate chain

of acetyl-CoA and prevents binding of substrate with enzyme.

In the

presence of an inhibitor such as ATP, Mg++ binds to the polyphosphate
moiety of this molecule and prevents it from occupying the acetyl-CoA
binding site.

Comprehensive reviews of the mechanism may be found

elsewhere (^8,73)•

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

B.

METABOLIC CONTROL OF CITRATE SYNTHASE

The discussion of metabolic control is organized as follows:
1)

General principles of metabolic control

2)

Observations and proposals related to in vivo control of CS by
a)
b)
c)
d)
e)
f)

3)

Citrate
Acetyl-CoA
Palraitoyl->CoA.
Fatty acids
OAA
Metal ions

Reported in vitro findings related to adenine nucleotides

and Mg++ effects on enzymes and in particular CS
k)

An analysis of our experimental data under the following

headings:
a)
b)
c)
d)
5)

Enzyme Content
Km and Ki values
Magnesium ion relief ofATPinhibition
Effect of the ATP-Mgcomplex onCS

The results of in vivo studies and a conclusion concerning

the control of CS by ATP

1) Principles of Control of CS
Metabolic pathways are successive conversions of molecules in
biological systems.

More elaborate metabolicschemes are usually found

in those organisms which readily adapt to new sources or to a wider
variety of compounds; these are used for fuel or for building blocks
during synthesis and maintenance of cellular structure and function.
Each pathway evolves to fill a need and therefore has specific, often
vital, functions.

Thus, at this stage another level of organization

develops which integrates all the pathways enabling them to coexist to
the advantage of the organism.

This force which serves to coordinate

all processes is metabolic control.
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The rate of conversion of metabolites is regulated by enzymes.
Each enzyme carries out a particular alteration in a molecule and so the
product of one reaction is the substrate for the next.

Then changing

the ability of an enzyme to catalyze a reaction, results in an altered
rate of metabolism.

The rate at which a metabolic reaction takes place

is governed by the amount of the required enzyme present and by the
activity of those enzyme molecules.
take place along two lines.

Thus, control of the reaction may

One is the regulation of synthesis and

degradation of the enzyme and another is the availability of effectors
(activators or inhibitors), substrate(s), and cofactors.

The latter is

the type of metabolic control under consideration in this discussion,
2)

Control of CS
a)

Citrate;

In addition to its well known role in the tri

carboxylic acid cycle, the following metabolic functions for citrate
have been suggested by Srere from in vitro studies (7*0; a) a source of
reducing power
enzyme activity,

b) a source of acetyl groups and c) a controller of
a)

Citrate may be transported out of the mitochondria

to the cytoplasm where its conversion to o(-ketoglutarate by means of
aconitase and isocitrate dehydrogenase results in the reduction of NADP,
a process necessary to have hydrogen available for synthetic reactions
in the cytoplasm (Diagram 3)•

b)

Srere and Bhaduri (75) showed that'

citrate could contribute to the acetyl-CoA pool and subsequently be used
for fatty acid synthesis.

The amount of citrate cleaved to OAA and

acetyl-CoA depended on the availability of free acetate for acetyl-CoA
formation,

c)

In addition to acting as an acetyl donor in fatty acid

synthesis, citrate has been reported to activate acetyl-CoA carboxylase.
Citrate (or isocitrate) was required for the carboxylation of acetyl-CoA
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to form malonyl-CoA in liver extracts (57) and either of these compounds
could stimulate this activity in other tissues (58).

The reaction

catalyzed by acetyl-CoA carboxylase has been shown to be rate limiting
(57.76,77,78).

Therefore, it has been suggested that the rate of fatty

acid synthesis is regulated by the intracellular concentration of citrate
(79,80).

If this is true, either the citrate content of liver might be

expected to parallel acetyl-CoA carboxylase activity or the activity of
this enzyme could be regulated by intracellular compartmentalization of
citrate.

Chance et al., (81) warn that the total cell concentration of

a metabolite is an average of the concentrations in organelles.

This

kind of analysis ignores transport of metabolites and may be meaningless
in terms of studying metabolic control.
Experiments have shown that changes in citrate content of liver
tissue are negligible when the nutritional state of the animal causes an
alteration of fatty acid synthesis (82).

Recently, Swanson et al.. (83)

have reported that rat liver acetyl-CoA carboxylase is activated by
incubation at 26°C.

The presence of citrate during incubation resulted

in greater activity.

More conclusive evidence for the role of citrate

(or isocitrate) in the activation of acetyl-CoA carboxylase has come
from the work of Ryder et al., (84) who used the enzyme from chicken liver.
It appears that citrate induces a conformational change in the protein
so that transfer of CO2 from the enzyrae-biotin complex to acetyl-CoA is
activated.
Since NADPH is required for fatty acid synthesis, citrate stimu
lation of fatty acid synthesis could be accounted for by its positive
effect on NADPH formation.

However, citrate has been shown to be a

better activator than other NADPH-generating systems (56),
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3k
Citrate (and fumarate) was observed to inhibit pig heart mito
chondrial MDH and was competitive with NADH (85)*

Compounds not showing

inhibition were isocitrate, maleate, succinate, cis-aconitate, aspartate,
glutamate, pyruvate and phosphoenolpyruvate.

Cytoplasmic MDH was inhibited

glucose
malate
A-NADP

cytoplasmic MDH
-%~
NADH
NAD

OAAacetyl-CoA
malonyl-CoA

citrate
cleavage
enzyme.

malic enzyme
NADPH

free fatty
acids

ATP,CoA
pyruvate^— > acetyl-CoA

citrate

..citrate

cis-aconitate

cis-aconitate
MDH

isocitrate

isocitrate

pyruvate
malate

> NADPH
oxalo succinate

oxalo succinate

V < -cK-ketoglutarate

>-

-ketoglutarate
CYTOPLASM

MITOCHONDRIA

Diagram 3
by none of these compounds.

This has been considered a possible means

whereby citrate regulates fatty acid synthesis in the cell.

The inhibi

tion of mitochondrial MDH by citrate prevents the formation of maleate
from OAA (favored by equilibrium) in the mitochondria (Diagram 3) • OAA
does not diffuse readily from the mitochondria (86).

OAA along with

acetyl-CoA in the mitochondria is converted by means of CS to citrate;
this compound is transported into the cytoplasm where cleavage yields
acetyl-CoA for fatty acid production and OAA.

The OAA may be converted
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to pyruvate by the action of cytoplasmic MDH and malic enzyme.

In this

way NADPH as well as acetyl-CoA become available for cytoplasmic fatty
acid synthesis,

Srere and Foster (53) observed that a twenty-four hour

fast caused a virtual cessation of fatty acid synthesis in rat liver.
There was a four-fold increase in the blood acetoacetate level.

Citrate

cleavage enzyme activity rose reaching a maximum after twelve hours
without foodc

After twenty-four hours the activity of this enzyme in the

livers of starved animals was no lower than that of fed animals.
activity level increased by approximately twenty-five per cent.

The CS
These

results indicate that a change in citrate cleavage enzyme level is not
directly the cause of change in fatty acid metabolism during starvation,
Shrago et al., (87) found that citrate cleavage enzyme, assayed according
to the method of Srere (88), was absent from human adipose tissue.
possible that fatty acids are not made in human adipose tissue;

It is

trigly

cerides made in the liver where citrate cleavage enzyme is found (87) nay
be transported in the blood to adipose tissue.
Citrate and isocitrate are the only tricarboxylic acid cycle
intermediates that inhibit pho sphoglucomutase,

The inhibition appears

to be due to the removal, by chelation, of %

which is necessary for

enzyme activity (8 9 ),

This is similar to the effect of citrate on

phosphofructokinase (90).
b)

Acetyl-CoA:

Acetyl-CoA is an important metabolic intermediate.

The control of reactions in which it participates determines whether
it is sent into the production of energy (tricarboxylic acid cycle),
fatty acids, keto acids or glucose,
an effector of enzyme activity.

Acetyl-CoA itself may function as

Acetyl-CoA is competitive with respect

to CoA in the pig heart pyruvate dehydrogenase reaction (91), Acetyl-CoA
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has been demonstrated to be an activator of pyruvate carboxylase.

This

enzyme is present in liver (92) and adipose tissue (93) in equal amounts.
Thus acetyl-CoA activation of pyruvate carboxylase could lead to the
conversion of pyruvate to fatty acids.
reduced.

During glycolysis coenzymes are

Fatty acid synthesis could function to oxidize these coenzymes

so that glucose would continue to be converted to acetyl-CoA (9*0«

In

the presence of a transhydrogenase system to convert NADH to NADPH, NAD+
is made available for continual glycolysis and acetyl-CoA production and
acetyl-CoA reduction to fatty acids by NADPH is enhanced.
Alternatively, activation of pyruvate carboxylase by acetyl-CoA
(95) in liver, when considered with the acetyl-CoA inhibition of pyruvate
kinase and glucokinase (96), could be interpreted as a mechanism to
stimulate gluconeogenesis.
c)

Palmitoyl-CoA:

CS (**5,97) and acetyl-CoA carboxylase are

reported to be inhibited by palraitoyl-CoA and other long-chain acyl
coenzyme A derivatives (98); only long-chain fatty acyl carnitine
derivatives relieve this inhibition (99*100),

However., in vivo studies

show that increased levels of palmitoyl-CoA are associated with increased
citrate levels (101,102,103).

Moreover, the decrease in liver citrate,

level on fasting was not large enough to account for the observed decrease
in liver fatty acid synthesis.

Srere (**5) has suggested that palmitoyl-CoA

does represent a physiologically significant control of metabolism.
This view is supported by the observation that palmitoyl-CoA is a non
specific inhibitor of many enzymes (10*0.
d)

Fatty Acids:

The inhibition of enzymes by fatty acids may

be a widespread phenomenon used by the cell to regulate metabolism.

Lea

and Weber (**7) report that octanoate inhibits key enzymes in glycolysis.
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Th© levels of octanoat© required for the above observations were high,
however, and make it an unlikely in vivo regulator.

Longer chain fatty

acids inhibited at concentrations within tho physiological range (^7).
e)

OAA:

The fates of oxalacetate within the cell have recently

been reviewed (105),

OAA exists in keto and enol forms.

The keto form

has been shown to be th© tautomer that binds to CS (33) and others have
suggested (106) that the enol fora of OAA inhibits succinic dehydrogenase.
The fact that the in vivo steady state concentration of OAA is much lower
than that of other tricarboxylic acid cycle intermediates (107) and the
discovery of an enzyme that catalyzes the tautomerization of OAA (72),
suggest a possibility for metabolic control by OAA.
In rat liver, the carboxylation of pyruvate is the major source
of OAA.

In beef liver, it is the conversion of propionate to OAA within

the mitochondria.
f)

Metal Ions:

It is known that metal ions and protons are trans

ported between the mitochondria and cytoplasm sometimes against concen
tration gradients (108,109,110,111,112).

Mg** has been shown to alter

the movement of citrate into and out of mitochondria (113) and Mg** is
present in relatively high concentration compared to other divalent
cations (69, Table 2).
‘
At physiological pH, ATP is predominantly in the tetraionic form
(11^).

When equimolar solutions of MgCl2 and ATP“^ were mixed in vitro.

the concentration of the complex, MgATP

2

, approached the initial concen

tration of ATP”^ used (115,116) because of the apparent formation constant
for MgATP”^ (e.g. 3100 moles-* litre (117,118)).

From independent reports

of the quantities of Mg** (69) and ATP (119) in rat liver, the ratio of
Mg**/ATP has been calculated to be 2.6 for whole cells.

Similarly, the
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ratio of Mg**/ATP in rat liver mitochondria is calculated to be 9.0 (69,
120,121).

Moreover, Ca** is also present in high levels in mitochondria

(Table II) and forms an even more stable complex with ATP (71).
amount of "free" ATP in the mitochondria may be very low.

Thus, the

ATP has been

observed to inhibit swelling of mitochondria in vitro (122)♦

It may be

that the concentration of divalent metal ion in the cell is regulated by
the ATP level.
3)

Control of CS bj ATP?
It appears that substrates and products of the CS reaction may

be widely distributed in the control of metabolism.

A reasonable assump

tion would be that CS itself is under careful metabolic control.

Initial

observations that adenine nucleotides inhibit CS led Atkinson et al. (5**,

60,62) to postulate that the energy level of the cell (reflected by the
ATP level) acts in a feedback mechanism to control the direction of
acetyl-CoA utilization.

When the ATP level in the cell is high, CS is

inhibited and acetyl-CoA is prevented from entering the tricarboxylic acid
cycle and from contributing to ATP production via electron transport.
Investigation of beef heart and beef liver enzymes led th© Atkinson group
(6*0 to reaffirm their-proposed regulation of CS by the "energy charge"
of the cell (123) expressed in the ratio ATP + -§ADP/AMP + ADP + ATP.

All

observations to date have demonstrated that ATP inhibits CS from a number
of sources (2*t,5^,59.60,61,62,63,6^,65,12*0 • Our results as reported
here are in agreement in this respect (Table I, columns d and e,f and h).
Th© effect of AMP on CS has been reported as negligible for the pig
heart enzyme (65) and low for the beef liver and beef heart enzymes (6*+).
AMP stimulation of NAD-specific isocitrate dehydrogenase (125)
supports this reasoning.

A similar mechanism appears operative for
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phosphofructkinase, an enzyme which is inhibited by ATP; 3,*5'-cyclic AMP,
.5*-AMP and ADP overcome this inhibtion (126),
^f)

Analysis of Our Data
In light of these observations, i^seemed important to examine

the inhibtion of CS by ATP and the effect of Mg** on this inhibition.
Crude extracts were used in order to minimize alteration of the behavior
of CS.

To approach physiological conditions in one respect, the divalent

metal ion, Mg

, was added to the in vitro system.

Tissues were chosen

so that results could be compared with previous observations.

More than

one species and different tissues within a species were examined for
differences in CS characteristics.
a) Enzyme Content:
other tissues.

Heart tissue contains more CS activity than

This would be expected for a rapidly respiring tissue.

Anaerobic yeast may have more CS activity than aerobically-grown cells
(See legend to Table I*).

This possibly indicates that the citrate

produced acts in a capacity to furnish NADPH (via isocitrat© dehydrogenase,
see Diagram 3) for fatty acid synthesis.
b) Km and Ki values:

.

ATP inhibition of CS is competitive with

respect to acetyl-CoA in each of these tissues.

The Km values in Table I

(column d) show that in the rat, liver and brain CS have lower Km values
(about ■§) than kidney and heart (i.e. concentrations of acetyl-CoA
required for half saturation of the enzyme).

The liver and brain enzymes

are inhibited to about the same extent by ATP (column e).
requires a higher level of ATP for inhibition.

Rat heart CS

Rat kidney CS is inhibited

when ATP levels are about twice those required for the same amount of CS
inhibition in rat liver and brain.

Beef heart and beef liver CS show

inhibition at relatively higher levels of ATP.

Beef heart CS has a lower
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Kin for acetyl-CoA than beef liver CS.

In the anaerobic yeast not only

is CS present to the extent of more than double the activity compared
to the enzyme in aerobically-grown yeast but it requires only 12 to 15
per cent the amount of acetyl-CoA needed for half maximal reaction in
the aerobic yeast CS reaction.

This could mean that in the aerobic

system more acetyl-CoA is produced because more reaction pathways are
open for acetyl-CoA utilization and an active control system probably
determines the amount of acetyl-CoA entering the tricarboxylic acid cycle.
Aerobic CS does not have to operate as efficiently as the anaerobic CS
since substrates may be present in higher concentrations.

The lower rate

of glycolysis expected in anaerobic yeast and the production of ethanol
from pyruvate may be partially compensated for by having a lower threshold
of acetyl-CoA concentration for citrate formation.

In Table I, by comparing

columns f and h, it is seen that higher concentrations of ATP cause more
inhibition of CS in all tissues.
c) Magnesium Ion Relief of ATP Inhibition:

Figure 3 is qualitatively

representative of results observed for CS in each of the extracts assayed.
The presence of Mg

4*+

causes a reversal of ATP inhibition and it appears

that most relief occurs when the Mg

concentration equals that of the

++
inhibitor, ATP; this reversal by Mg
isseen in Figure 3 and also in
Table I by comparing column f with g and h with i.
have been made using Ca

instead of Mg

Similar observations

(59)•

d) Effect of the ATP-Mg Complex on CS: In order to observe the
effect of ATP on CS in the presence of an equal amount of Mg

4~4*

, experiments

were carried out over a wide range of ATP concentrations under the
44
condition of increasing concentrations of ATP and Mg
at a fixed molar
ratio of one to one.

Results of experiments run at constant ionic strength
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show that the ATP-Mg complex does not inhibit beef heart CS (Fig, 4),
Similar results were found using crystalline pig heart CS,

It follows

that the values for per cent activity in columns g and i (Table I)
should approach one hundred since the ATP-Mg complex does not inhibit CS.
The observed differences might be explained in terms of the following
consecrations;

In those experiments reported in Table I, the ionic

strength varied according to the amount of ATP present.

This was

compensated for by using a "standard curve" of per cent activity versus
ionic strength.

However, the standard curve was constructed from data

obtained using crystalline pig heart CS and the response of CS in crude
extracts of other species and tissues to ionic strength changes are not
necessarily the same.
competition for Mg

++

Another possible explanation might be that the
between ATP and other compounds present, especially

acetyl-CoA, may vary with ionic strength.

This would affect the amount

of "free" ATP.
5)

Inj^y/o Studies
Mg

has been shown to change the pH optimum of plant alkaline

fructose diphosphatase (127) and may have a role in the determination of
stereospecific structure during enzymatic reactions (128),
The observation that ATP is not inhibitory to CS when bound to
Mg++ (Fig. k) and the fact that Mg** levels in the cell are high (Table II),
raise doubt at this time as to the importance of ATP in the direct
regulation of CS activity.

Much of the accumulated data has been obtained

from in vitro systems; under these conditions, the enzyme concentration
used is usually several fold less than in vivo and in many cases this
results in an altered behavior of the enzyme (129).

Williamson et al.

(130) have carried out experiments using isolated respiring mitochondria.
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The results suggest that CS activity is not significantly controlled by
the concentration of ATP in the mitochondria; the redox state of pyridine
nucleotides in the mitochondria appears to control the rate of the CS
reaction by regulating the formation of OAA and its availability for
condensation with acetyl-CoA.
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CHAPTER

SUMMARY

In rat tissues, heart contains considerably more (k to 7 times)
CS activity than liver, kidney or brain.

Beef heart is more active (15

to 16 times) than beef liver with respect to CS activity.

Anaerobic

yeast have approximately double the CS activity found in aerobic yeast.
ATP in a concentration 20 to 200 times that of acetyl-CoA
inhibits CS in crude extracts of several tissues.
competitive with respect to acetyl-CoA.

This inhibition is

With increasing concentrations

of ATP, a decrease in activity is observed until a minimum level of.CS
activity is reached at 80 per cent of that observed for a control
reaction.
tissue.

Variation in Km and Ki values are observed from tissue to
There is no direct correlation between the relative amounts

of acetyl-CoA necessary for half saturation of the enzyme (Km) and the
amount of ATP required for 50 per cent inhibition (Ki) in the tissues
studied.

Of all these tissues, anaerobic yeast requires the least

acetyl-CoA for half saturation of the enzyme.
Mg

is inhibitory to CS when used in a concentration 100 fold

greater than the concentration of acetyl-CoA,
relieves the inhibition of CS by ATP.

In low concentration, Mg

When Mg4"* and ATP are present in

low or high concentrations, no inhibition is observed as long as the
molar ratio of Mg++/ATP is one.

The effect of Mg4"1" appears to be the

result of chelation of the divalent metal with the polyphosphate chain
of molecules.

In the case of acetyl-CoA, Mg

chelation inhibits the

normal reaction by preventing this substrate from binding with the
-1, - 1 ,

polyphosphate moiety to the enzyme.

In the case of ATP, Mg

43
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chelates

with the polyphosphate group of ATP and prevents It from inhibiting the
enzymatic reaction.

This information is useful to the understanding of

the mechanism of the reaction.
The high intracellular concentration of Mg+* casts doubt upon
the physiological importance of ATP as a regulator of CS.

In vivo

studies by other workers also indicate that ATP has no direct role in the
regulation of CS activity.
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ZZF0RX5
DIMENSION Y (60)tX(60)
C
LEAST SQUARES ANALYSIS OF 1/V VS. 1/S DATA
C
PUT UNINHIBITED DATA FOR A RUN FIRST
C
FOLLOWED IMMEDIATELY BY INHIBITED DATA
C
R=RUN NO.
C
N =NO. OF POINTS ON 1/V VS. 1/S PLOT
C
Y=l/V, X=l/S
C
VMAX1. UV MAX 1,K M1 ,KI 1 ARE VALUES WITH THE MAXIMUM +VE STANDARD
C
ERRORS CARRIED THRU THE CALCULATION^
IJK= O
1 READ 2.R.N
2 F O R M A T (A3. 14 >
IF(N — 9999 > 3,8,3
3 READ 4, (Y(I)«X(I). 1=1 iN)
4 F O R M A T (6(F 5 .1 .F6.0) )
SX = 0.
SY = 0.
SXY = 0.
SXX=0.
SYY=0.
'
.
DO 5 l - l t N
.
S X = S X + X ( I)
SY = S Y + Y < I )
SXY = SXY + X ( I )* Y ( I )
SXX-SXX+XCI )*X( I )
S Y Y = S Y Y + Y ( I)* Y (I )
5 CONTINUE
C =N
IF(IJK)7.6.7
6 USLOPE=(SX*SY-C*SXY)/(SX*SX-C*SXX>
U Y I N T = (SX*SXY-SXX*SY)/ (SX*SX-C*SXX)
UXINT=-UYINT/USLOPE
AKM = - 1./UXI NT
UVMAX =1 ./UYINT
USTDEY=( ( 1 . / C ) * S Y Y - ( S Y / C ) * * 2 ) * * 0 . 5
U S T D E X = ( < l . / C ) * S X X —( S X / C ) * * 2 ) * * 0 . 5
URR=( < 1 . / C ) * S X Y - ( S X / C ) * ( S Y / C ) )/(USTDEY*USTDEX)

C

IJK= IJl<+ 1
IF(URR— 1•) 20,21.21
20 USTE RY= US TDE Y*< 1.-<URR*URR))**0.5
US TERX=USTDEX*(1,-(URR*URR))**0.5
AKM 1=-1 «/(UXI NT + U S T E R X )
U V M A X 1= 1 ./(UYINT+USTERY) .
GO TO 1
7 SLOPE= (SX*SY-C*SXY)/(SX*SX-C*SXX)
Y INT = (SX*SXY —S X X * S Y )/(SX* SX —C * S X X )
XINT = -YI NT/SLOPE
V M A X - 1./YINT
Bl< I=-0. 005*AKM*X INT/( 1 .+AKM*X INT )
N.B.* * * * 0 .0 05= INHIdITOR CONCENTRATION IN MOLES/L
S T D D E Y = ((1./C)*SYY-(SY/C}**2)**0.5
S T D D E X = ((1./C)*SXX-(SX/C)**2)**0.5
RR= ((l./C) *SXY- (SX/C) * (SY/C ) )/ (ST.DOEY*STDDEX )
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IJK-0
IFCRR-1.) 22,21.21
22 STDERY = STDDEY* ( 1 •— (RR-*RR ) )**0.5
STDERX=STDDEX*( 1 ,-!RR*RR) )**0 .5
VMAX1 = 1 •/!YlNT + S T D E R Y >
SKI 1 =(-0.0 0 5 * A K M l * t X I N T - S T D E R X ) )/( 1 »+ A K M 1 *(X I N T - S T D E R X ) )
P UNCH 10 0,R

100 F O R M A T (8HRUN N0.=,A3)
PUNCH 202,URR
2 0 2 F O R M A T (3 7 H C 0 R R E L A T I ON

C O E F F I C I E N T !UN INHIBI T E D > = *E 1O .3)

PUNCH 203,RR
203 F O R M A T (35HCORRELATI ON COEFFICI E N T ( INHIoI T E D )=,E 10.3>
PUNCH 205,USTERY,USTERX
205 FORMAT!5HUERY=,El 0.3,5 X, 5HU E R X = , E 10.3)
PUNCH 2 0 4 , S T D E R Y ,STDERX
204 F0RMAT(4HERY=,E10.3,5X,4HERX=,E10.3)
PUNCH 200.UVMAX1,AKM1
200 FORMAT!37X.7HUVMAX1=,E 10.3,2 X ,4 H K M 1=,El0.3)
PUNCH 101 ,UYI N T ,UX INT,U V M A X ,AKM
101 FORMAT (6HUY INT=*E10.3»3X,6HUXINT=,E10.3,3X, 6HUVMAX= ,E 10 »3 ,3 X ,3H.= ,E 10 •3 )
PUNCH 201 ,VMAX1 ,BI<I 1
201 FORMAT!38X.6HVMAX1=,E 10.3,2 X ,4HKI 1= ,E10.3)
PUNCH 102»YINT,VMAX,BKI
102 FORMAT! 1X ,SHY IN T =♦E 10.3,2 3 X ,5 H V M A X = ,E 10.3,3 X ,3 H K 1-,E 10.3//)
GO TO 1
21 PUNCH 300,R
300 FORMAT!A3.5X,15HCANN0T EVALUATE)
25 GO TO 1
8 CALL EXIT
END
ZZZZ8
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